Atsena Therapeutics
PrivateLast Round
Series C
Apr 2, 2025
Est. Valuation
$340M
Total Funding Raised
$237.65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Atsena Therapeutics is a biotechnology company that develops ocular gene therapies aimed at reversing or preventing blindness caused by inherited retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atsena Therapeutics Comparables
Compare Atsena Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Opus Genetics | 86% | |
| Beacon Therapeutics | 85% | |
| SpliceBio | 81% | |
Atsena Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 2, 2025 | ||||
| Series B | Oct 2, 2023 | ||||
| Series A | Dec 16, 2020 | ||||
| Series 1 | Apr 1, 2020 |
Key People
Founding team and executive leadership
Atsena Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Life Sciences | Series C |
| Lightstone Ventures | Series A, Series C, Series B |
| Hatteras Venture Partners | Series A, Series C, Series B, Series 1 |
| Osage University Partners | Series A, Series C, Series B, Series 1 |
| The Manning Family Foundation | Series A, Series B, Series C |
| PBM Capital Group | Series 1 |
| Abingworth | Series A, Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2026
Grew 15% QoQ, from 39 to 45 employees.
- May 17, 2026
Monthly visitors grew 115% MoM, reaching 18.9K.
Atsena Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Atsena Therapeutics's valuation, stock price, and market status.